Europe Dog Dewormers Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Injectable, Topical), By Dosage Form (Liquids, Tablets), By Type (OTC, Prescription), By Distribution Channel, By Country, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 2 Business Days
Europe Dog Dewormers Market Growth & Trends
The Europe dog dewormers market size is expected t%li%reach USD 376.7 million in 2030 and is estimated t%li%grow at a CAGR of 7.76% from 2025 t%li%2030, according t%li%a new report by Grand View Research, Inc. Rising canine population coupled with their ownership and growing expenditure on dogs are major drivers propelling the market growth. FEDIAF’s 2022 report indicated that Europe’s pet-owning households reached 90 million (i.e. 46%) in 2021, and among these households live approximately 92.9 million dogs. Furthermore, the European population spends around USD 24.5 Billion on pet-related services and products each year, according t%li%European Pet Food Industry. Similarly, according t%li%data published by N26 GmbH in October 2020, around USD 15.8 t%li%USD 52.8 (EUR 15-50) per month is spent on dog insurance, depending on their breed.
Various government organizations in Europe were actively monitoring the impact of COVID-19 on veterinary medicines supply chains. As per FVE (Federation of Veterinarians of Europe) in July 2021, veterinary services for companion animals in the region have been highly impacted during the mid of 2020, as only emergency and urgent treatments were allowed as per the government regulations. However, veterinary businesses quickly recovered with the support of e-commerce sales channels and the implementation of enormous government initiatives t%li%continue veterinary healthcare practices.
For instance, in March 2020, FVE stated that veterinary services in Europe are considered one of the most essential businesses and will be continuing despite the ongoing pandemic. Veterinarians, vet clinics, and key market players have implemented various strategies t%li%revive their services. Countries like the U.K. and France, have shifted towards digital vet consultations for essential pet care and proceeding with the online supply of dog dewormer products.
The Europe dog dewormers industry is expected t%li%grow notably in the coming years. This can be attributed t%li%the well-established veterinary care infrastructure, a large dog population, and the local presence of key companies. According t%li%the annual report of FEDIAF 2022 (the European Pet Food Industry), the countries like Russia, the U.K., Germany, Spain, France, and Italy were registered t%li%have households owning more than 7 million dogs.
The market is reasonably competitive. The most notable participants in the market include Merck & Co., Inc., Boehringer Ingelheim International GmbH, Ceva, Sava Healthcare, Beaphar, and Bob Martin, among others. These players are involved in acquisitions, new product launches, collaborations, geographical expansions, and partnerships t%li%gain a competitive edge over each other. In January 2021, Boehringer Ingelheim International GmbH announced marketing authorization approval in Europe for NexGard products, which are used as antiparasitics in dogs and cats. The approval was granted by European Medicines Agency (EMA) and European Commission.
Europe Dog Dewormers Market Report Highlights
Europe Dog Dewormers Market Growth & Trends
The Europe dog dewormers market size is expected t%li%reach USD 376.7 million in 2030 and is estimated t%li%grow at a CAGR of 7.76% from 2025 t%li%2030, according t%li%a new report by Grand View Research, Inc. Rising canine population coupled with their ownership and growing expenditure on dogs are major drivers propelling the market growth. FEDIAF’s 2022 report indicated that Europe’s pet-owning households reached 90 million (i.e. 46%) in 2021, and among these households live approximately 92.9 million dogs. Furthermore, the European population spends around USD 24.5 Billion on pet-related services and products each year, according t%li%European Pet Food Industry. Similarly, according t%li%data published by N26 GmbH in October 2020, around USD 15.8 t%li%USD 52.8 (EUR 15-50) per month is spent on dog insurance, depending on their breed.
Various government organizations in Europe were actively monitoring the impact of COVID-19 on veterinary medicines supply chains. As per FVE (Federation of Veterinarians of Europe) in July 2021, veterinary services for companion animals in the region have been highly impacted during the mid of 2020, as only emergency and urgent treatments were allowed as per the government regulations. However, veterinary businesses quickly recovered with the support of e-commerce sales channels and the implementation of enormous government initiatives t%li%continue veterinary healthcare practices.
For instance, in March 2020, FVE stated that veterinary services in Europe are considered one of the most essential businesses and will be continuing despite the ongoing pandemic. Veterinarians, vet clinics, and key market players have implemented various strategies t%li%revive their services. Countries like the U.K. and France, have shifted towards digital vet consultations for essential pet care and proceeding with the online supply of dog dewormer products.
The Europe dog dewormers industry is expected t%li%grow notably in the coming years. This can be attributed t%li%the well-established veterinary care infrastructure, a large dog population, and the local presence of key companies. According t%li%the annual report of FEDIAF 2022 (the European Pet Food Industry), the countries like Russia, the U.K., Germany, Spain, France, and Italy were registered t%li%have households owning more than 7 million dogs.
The market is reasonably competitive. The most notable participants in the market include Merck & Co., Inc., Boehringer Ingelheim International GmbH, Ceva, Sava Healthcare, Beaphar, and Bob Martin, among others. These players are involved in acquisitions, new product launches, collaborations, geographical expansions, and partnerships t%li%gain a competitive edge over each other. In January 2021, Boehringer Ingelheim International GmbH announced marketing authorization approval in Europe for NexGard products, which are used as antiparasitics in dogs and cats. The approval was granted by European Medicines Agency (EMA) and European Commission.
Europe Dog Dewormers Market Report Highlights
- By route of administration, the oral segment held the highest market share in 2024 and is anticipated t%li%grow at the highest CAGR of 8.75% over the forecast period
- By dosage form, liquids held the highest share in 2024. This segment includes medications like semi-solid topical, oral, and injectable liquids.
- By type, the prescription segment dominated in terms of market share in 2024 and is expected t%li%grow at the highest growth rate in the forecast period
- The veterinary hospitals/clinics segment is estimated t%li%hold the largest market share of 40.08% in 2024 owing t%li%the trust pet owners place in professional veterinary guidance for parasite control.
- The UK dog dewormers market is experiencing lucrative growth due t%li%growing efforts t%li%structure and upgrade regulatory guidelines surrounding veterinary medicines
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Global Market: CAGR Calculation
1.8. List of Secondary Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. EUROPE DOG DEWORMERS MARKET VARIABLE TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Awareness and Education Efforts Regarding Parasitic Worms
3.2.1.2. Growing Importance of Parasite Control in Dogs
3.2.1.3. Increasing Expert Scrutiny
3.2.1.4. Increasing of Zoonotic Diseases Transfer from Pets
3.2.1.5. Evolving Regulations
3.2.1.6. Emergence of New Parasitic Worms
3.2.2. Market Restraint Analysis
3.2.2.1. Development of Drug Resistance
3.2.2.2. Emergence of Unverified Treatments
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Europe Dog Dewormers Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental Landscape
3.3.3. Regulatory Framework
3.3.4. Estimated Animal Population, by Key Countries and Key Species, 2018-2024
3.3.5. Pricing Analysis
3.3.6. COVID-19 Impact Analysis
CHAPTER 4. EUROPE DOG DEWORMERS MARKET: ROUTE OF ADMINISTRATION ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Europe Dog Dewormers Market Route of Administration Movement Analysis
4.3. Europe Dog Dewormers Market Size & Trend Analysis, By Route of Administration, 2018 - 2030 (USD Million)
4.3.1. Oral
4.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.3.2. Injectable
4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.3.3. Topical
4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. EUROPE DOG DEWORMERS MARKET: DOSAGE FORM ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Europe Dog Dewormers Market Dosage Form Movement Analysis
5.3. Europe Dog Dewormers Market Size & Trend Analysis, By Dosage Form, 2018 - 2030 (USD Million)
5.3.1. Liquids
5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.2. Tablets
5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. EUROPE DOG DEWORMERS MARKET: TYPE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Europe Dog Dewormers Market Type Movement Analysis
6.3. Europe Dog Dewormers Market Size & Trend Analysis, By Type, 2018 - 2030 (USD Million)
6.3.1. OTC
6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.2. Prescription
6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. EUROPE DOG DEWORMERS MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Europe Dog Dewormers Market Distribution Channel Movement Analysis
7.3. Europe Dog Dewormers Market Size & Trend Analysis, By Distribution Channel, 2018 - 2030 (USD Million)
7.3.1. Veterinary Hospitals/Clinics
7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Retail/Pet Stores
7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. E-commerce
7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. EUROPE DOG DEWORMERS MARKET: COUNTRY ESTIMATES & TREND ANALYSIS, BY ROUTE OF ADMINISTRATION, DOSAGE FORM, TYPE, & DISTRIBUTION CHANNEL
8.1. Country Dashboard
8.2. Europe Dog Dewormers Market Share, By Region, 2023 & 2030 (USD Million)
8.3. Country Outlook
8.3.1. Spain
8.3.1.1. Key Country Dynamics
8.3.1.2. Spain Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.2. Germany
8.3.2.1. Key Country Dynamics
8.3.2.2. Germany Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.3. Portugal
8.3.3.1. Key Country Dynamics
8.3.3.2. Portugal Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.4. Romania
8.3.4.1. Key Country Dynamics
8.3.4.2. Romania Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.5. Slovakia
8.3.5.1. Key Country Dynamics
8.3.5.2. Slovakia Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.6. Czech
8.3.6.1. Key Country Dynamics
8.3.6.2. Czech Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.7. Hungary
8.3.7.1. Key Country Dynamics
8.3.7.2. Hungary Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.8. Poland
8.3.8.1. Key Country Dynamics
8.3.8.2. Poland Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.9. Italy
8.3.9.1. Key Country Dynamics
8.3.9.2. Italy Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.10. Ireland
8.3.10.1. Key Country Dynamics
8.3.10.2. Ireland Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.11. UK
8.3.11.1. Key Country Dynamics
8.3.11.2. UK Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.12. France
8.3.12.1. Key Country Dynamics
8.3.12.2. France Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.13. Denmark
8.3.13.1. Key Country Dynamics
8.3.13.2. Denmark Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.14. Sweden
8.3.14.1. Key Country Dynamics
8.3.14.2. Sweden Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.15. Norway
8.3.15.1. Key Country Dynamics
8.3.15.2. Norway Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Market Participant Categorization
9.2. Participants Overview
9.3. Financial Performance
9.4. Product Benchmarking
9.5. Market Position Analysis, 2024 (Heat Map Analysis)
9.6. Strategy Mapping
9.6.1. Mergers And Acquisitions
9.6.2. Launch
9.6.3. Partnerships & Collaborations
9.6.4. Expansion
9.6.5. Others
9.7. Company Profiles
9.7.1. Zoetis
9.7.1.1. Participant’s overview
9.7.1.2. Financial performance
9.7.1.3. Product Benchmarking
9.7.1.4. Strategic initiatives
9.7.2. Boehringer Ingelheim
9.7.2.1. Participant’s overview
9.7.2.2. Financial performance
9.7.2.3. Product Benchmarking
9.7.2.4. Strategic initiatives
9.7.3. Merck & Co. Inc.
9.7.3.1. Participant’s overview
9.7.3.2. Financial performance
9.7.3.3. Product Benchmarking
9.7.3.4. Strategic initiatives
9.7.4. Dechra Pharmaceuticals Plc.
9.7.4.1. Participant’s overview
9.7.4.2. Financial performance
9.7.4.3. Product Benchmarking
9.7.4.4. Strategic initiatives
9.7.5. Elanco Animal Health
9.7.5.1. Participant’s overview
9.7.5.2. Financial performance
9.7.5.3. Product Benchmarking
9.7.5.4. Strategic initiatives
9.7.6. Ceva Sante Animale
9.7.6.1. Participant’s overview
9.7.6.2. Financial performance
9.7.6.3. Product Benchmarking
9.7.6.4. Strategic initiatives
9.7.7. Virbac
9.7.7.1. Participant’s overview
9.7.7.2. Financial performance
9.7.7.3. Product Benchmarking
9.7.7.4. Strategic initiatives
9.7.8. Vetoquinol
9.7.8.1. Participant’s overview
9.7.8.2. Financial performance
9.7.8.3. Product Benchmarking
9.7.8.4. Strategic initiatives
9.7.9. Bioveta, a.s.
9.7.9.1. Participant’s overview
9.7.9.2. Financial performance
9.7.9.3. Product Benchmarking
9.7.9.4. Strategic initiatives
9.7.10. PetIQ, LLC
9.7.10.1. Participant’s overview
9.7.10.2. Financial performance
9.7.10.3. Product Benchmarking
9.7.10.4. Strategic initiatives
9.8. List of Other Market Players
CHAPTER 10. KEY TAKEAWAYS
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Global Market: CAGR Calculation
1.8. List of Secondary Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. EUROPE DOG DEWORMERS MARKET VARIABLE TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Awareness and Education Efforts Regarding Parasitic Worms
3.2.1.2. Growing Importance of Parasite Control in Dogs
3.2.1.3. Increasing Expert Scrutiny
3.2.1.4. Increasing of Zoonotic Diseases Transfer from Pets
3.2.1.5. Evolving Regulations
3.2.1.6. Emergence of New Parasitic Worms
3.2.2. Market Restraint Analysis
3.2.2.1. Development of Drug Resistance
3.2.2.2. Emergence of Unverified Treatments
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Europe Dog Dewormers Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental Landscape
3.3.3. Regulatory Framework
3.3.4. Estimated Animal Population, by Key Countries and Key Species, 2018-2024
3.3.5. Pricing Analysis
3.3.6. COVID-19 Impact Analysis
CHAPTER 4. EUROPE DOG DEWORMERS MARKET: ROUTE OF ADMINISTRATION ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Europe Dog Dewormers Market Route of Administration Movement Analysis
4.3. Europe Dog Dewormers Market Size & Trend Analysis, By Route of Administration, 2018 - 2030 (USD Million)
4.3.1. Oral
4.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.3.2. Injectable
4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.3.3. Topical
4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. EUROPE DOG DEWORMERS MARKET: DOSAGE FORM ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Europe Dog Dewormers Market Dosage Form Movement Analysis
5.3. Europe Dog Dewormers Market Size & Trend Analysis, By Dosage Form, 2018 - 2030 (USD Million)
5.3.1. Liquids
5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.2. Tablets
5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. EUROPE DOG DEWORMERS MARKET: TYPE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Europe Dog Dewormers Market Type Movement Analysis
6.3. Europe Dog Dewormers Market Size & Trend Analysis, By Type, 2018 - 2030 (USD Million)
6.3.1. OTC
6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.2. Prescription
6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. EUROPE DOG DEWORMERS MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Europe Dog Dewormers Market Distribution Channel Movement Analysis
7.3. Europe Dog Dewormers Market Size & Trend Analysis, By Distribution Channel, 2018 - 2030 (USD Million)
7.3.1. Veterinary Hospitals/Clinics
7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Retail/Pet Stores
7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. E-commerce
7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. EUROPE DOG DEWORMERS MARKET: COUNTRY ESTIMATES & TREND ANALYSIS, BY ROUTE OF ADMINISTRATION, DOSAGE FORM, TYPE, & DISTRIBUTION CHANNEL
8.1. Country Dashboard
8.2. Europe Dog Dewormers Market Share, By Region, 2023 & 2030 (USD Million)
8.3. Country Outlook
8.3.1. Spain
8.3.1.1. Key Country Dynamics
8.3.1.2. Spain Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.2. Germany
8.3.2.1. Key Country Dynamics
8.3.2.2. Germany Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.3. Portugal
8.3.3.1. Key Country Dynamics
8.3.3.2. Portugal Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.4. Romania
8.3.4.1. Key Country Dynamics
8.3.4.2. Romania Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.5. Slovakia
8.3.5.1. Key Country Dynamics
8.3.5.2. Slovakia Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.6. Czech
8.3.6.1. Key Country Dynamics
8.3.6.2. Czech Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.7. Hungary
8.3.7.1. Key Country Dynamics
8.3.7.2. Hungary Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.8. Poland
8.3.8.1. Key Country Dynamics
8.3.8.2. Poland Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.9. Italy
8.3.9.1. Key Country Dynamics
8.3.9.2. Italy Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.10. Ireland
8.3.10.1. Key Country Dynamics
8.3.10.2. Ireland Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.11. UK
8.3.11.1. Key Country Dynamics
8.3.11.2. UK Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.12. France
8.3.12.1. Key Country Dynamics
8.3.12.2. France Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.13. Denmark
8.3.13.1. Key Country Dynamics
8.3.13.2. Denmark Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.14. Sweden
8.3.14.1. Key Country Dynamics
8.3.14.2. Sweden Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.15. Norway
8.3.15.1. Key Country Dynamics
8.3.15.2. Norway Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Market Participant Categorization
9.2. Participants Overview
9.3. Financial Performance
9.4. Product Benchmarking
9.5. Market Position Analysis, 2024 (Heat Map Analysis)
9.6. Strategy Mapping
9.6.1. Mergers And Acquisitions
9.6.2. Launch
9.6.3. Partnerships & Collaborations
9.6.4. Expansion
9.6.5. Others
9.7. Company Profiles
9.7.1. Zoetis
9.7.1.1. Participant’s overview
9.7.1.2. Financial performance
9.7.1.3. Product Benchmarking
9.7.1.4. Strategic initiatives
9.7.2. Boehringer Ingelheim
9.7.2.1. Participant’s overview
9.7.2.2. Financial performance
9.7.2.3. Product Benchmarking
9.7.2.4. Strategic initiatives
9.7.3. Merck & Co. Inc.
9.7.3.1. Participant’s overview
9.7.3.2. Financial performance
9.7.3.3. Product Benchmarking
9.7.3.4. Strategic initiatives
9.7.4. Dechra Pharmaceuticals Plc.
9.7.4.1. Participant’s overview
9.7.4.2. Financial performance
9.7.4.3. Product Benchmarking
9.7.4.4. Strategic initiatives
9.7.5. Elanco Animal Health
9.7.5.1. Participant’s overview
9.7.5.2. Financial performance
9.7.5.3. Product Benchmarking
9.7.5.4. Strategic initiatives
9.7.6. Ceva Sante Animale
9.7.6.1. Participant’s overview
9.7.6.2. Financial performance
9.7.6.3. Product Benchmarking
9.7.6.4. Strategic initiatives
9.7.7. Virbac
9.7.7.1. Participant’s overview
9.7.7.2. Financial performance
9.7.7.3. Product Benchmarking
9.7.7.4. Strategic initiatives
9.7.8. Vetoquinol
9.7.8.1. Participant’s overview
9.7.8.2. Financial performance
9.7.8.3. Product Benchmarking
9.7.8.4. Strategic initiatives
9.7.9. Bioveta, a.s.
9.7.9.1. Participant’s overview
9.7.9.2. Financial performance
9.7.9.3. Product Benchmarking
9.7.9.4. Strategic initiatives
9.7.10. PetIQ, LLC
9.7.10.1. Participant’s overview
9.7.10.2. Financial performance
9.7.10.3. Product Benchmarking
9.7.10.4. Strategic initiatives
9.8. List of Other Market Players
CHAPTER 10. KEY TAKEAWAYS
